HPLC法测定长效异乐定胶囊中5—单硝酸异山梨酯的含量

用反相高效液相色谱法测定了长效异乐定胶囊中５－单硝酸异山梨酯的含量。色谱柱为ＹＷＧ－ＯＤＳ Ｃ１８（２５０ｍｍ×４．６ｍｍＩ．Ｄ，５μｍ）；流动相为甲醇－水（１：１）；检测波长为２３０ｎｍ。本法测定平均回收率为９９．２９％，ＲＳＤ＝０．２４％；日内精密度ＲＳＤ为０．３２％；日间精密度ＲＳＤ为０．９２％。与比色法比较，本法测定结果准确可靠。     

多波长吸收度比值法测定安痛定注射液中氨基比林和安替比林

采用文献报道的多波长吸收度比值法，直接同时测定安痛定注射液中氨基比林和安替比林二者的含量。其平均回收率分别为：氨基比林９９．９４％，ＲＳＤ＝０．１５％；安替比林９９．５０％，ＲＳＤ＝０．９３％。     

反相高效液相色谱法测定丁卡因和利多卡因含量

目的 采用反相高效液相色谱法同时测定丁卡因和利多卡因的含量。方法 ＯＤＳ色谱柱、检测波长２６３ｎｍ，以乙腈－０．１％硫酸三乙胺中液（６０：４０）为流动相，流速０．５ｍｌ／ｍｉｎ。结果 丁卡因在０．１￣０．５ｇ／Ｌ浓度范围内呈线性关系，平均回收率１０１．８％，ＲＳＤ为０．７％（ｎ＝４）；利多卡因在０．１５￣０．７５ｇ／Ｌ浓度范围内呈线性关系，平均回收率９９．５３％，ＲＳＤ为０．９％（ｎ＝４）。结论     

HPLC法测定氯唑沙宗片含量

本文采用ＨＰＬＣ测定氯唑沙宗片中氯唑沙宗含量。以甲醇：水（５０：５０）为流动相，非那西丁为内标，在２８０ｎｍ处检测。其平均回收率为９９．９３％，ＲＳＤ＝０．５５％，方法简便，准确。     

多波长吸收度比值法测定安痛定注射液中氨基比林和安替林比

采用文献报道的多波长吸收度比值法，直接同时测定安痛定注射液中氨基比林和安替比林二者的含量，其平均回收率分别为：氨基比林９９．９４％，ＲＳＤ＝０．１５％，安替比林９９．５０％，ＲＳＤ＝０．９３％。     

HPLC法测定癣可净软膏的含量

用反相高效液相色谱法测定癣可净软膏的含量。以非那西丁为内标，甲醇－水为流动相，紫外检测波长为２８５ｍｍ。本法开始３．５ｍｉｎ内以６０％甲醇－水为流动相，３．５～１３．０ｍｉｎ内以１００％甲醇为流动相。平均回收率为９８．９％，ＲＳＤ＝０．５５％；日内精密度ＲＳＤ为１．３２％，日间精密度为１．８２％。     

高效液相色谱法测定复方补血口服液中黄芪甲甙的含量

以高效液相色谱法测定复方补血口服液中黄芪甲甙的含量，用ＹＷＧ－Ｇ１８柱（４．０×１５０ｍｍ），在流动相为甲醇－水（５０：５０）；流速炎０．５ｍｌ／ｍｉｎ；检测波长为２０１ｎｍ；柱温为３０℃的色谱条件下，就快速有效地分离和测定复方补血口服液中黄芪甲甙的含量，其平均回收率９８．５４％，ＲＳＤ＝４．５％，线性范围为７．２５－５８．００ｍｇ／ｍｌ。     

UV法测定甲钴胺片剂及注射液的含量

采用紫外分光光度法测定甲钴胺片剂及注射液的含量。检测波长为２６４ｎｍ。本方法线性范围为１０～５０μｇ／ｍｌ（ｒ＝０９９９９），片剂的平均回收率为１０００２％（ｎ＝５），ＲＳＤ为０７％；注射液的平均回收率为９９９５％，ＲＳＤ为０２％。     

健延龄胶囊中大黄素,大黄素甲醚的含量测定

目的：测定健延龄胶囊中大黄素、大黄素甲醚的含量。方法：采用薄层扫描法。结果：１０批样品中大黄素平均含量为１．９９３‰，平均加样回收率９９．０８％，ＲＳＤ为３．０９４％；大黄素甲醚平均含量为０．８４５‰，平均加样回收率９９．１２％，ＲＳＤ为２．８１８％。结论：该方法为健延龄胶囊的质量控制提供了依据。     

HPLC法测定凉山杜鹃中槲皮素的含量

目的：应用ＨＰＬＣ法对凉山杜鹃中槲皮素的含量进行测定。方法：选用Ｓｈｉｍ－ｐａｃｋＣＬＣ－ＯＤＳ分析柱（１５０ｍｍ×６．０ｍｍ,５μｍ）甲醇－０．５％磷酸（５０．５０）为流动相,检测波长为３７０ｍｍ,流速１．０ｍＬ／ｍｉｎ结果：线性范围：０．０８～０．４μｇ（ｒ＝０．９９９９）平均回收率９６．４８％,ＲＳＤ为１．５％,结论：本法简便,灵敏,准确,重现性好。     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.     

Expression of OPGmRNA and ODFmRNA in the patients of hip fracture due to osteoporosis

Objective：To investigate the gene expression of osteoprotegerin（OPG） and osteoclast differentiation factor（ODF） in the bone tissue of patients with hip fracture due to osteoporosis. Methods：OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers（over 50 years old） with hip fracture（Observer Group） and 30 cases of hip facture sufferers with no osteoporosis（Control group） were analyzed with the Semi-Quantitative RT-PCR method. Results：The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion：Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.     

The clinicopathological and immuohistochemical analysis of solid-pseudopapillary tumor of the pancreas： report of 9 cases

Objective：To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas（SPTP）. Methods：Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin（HE） staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results：Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin（9/9 cases）, AAT（9/9 cases）, NSE（9/9 cases）, ACT（7/9 cases）, CK20（2/9 cases）, CgA（1/9 cases）, S-100（3/gcases）, PR（4/gcases）, Syn（3/9 cases） and CD56（5/9cases）, negative in CEA and ER. Conclusion：SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.     

Electro-Acupuncture Combined with the Trigger Point Needle-Embedding for Treatment of Primary Trigeminal Neuralgia in 31 Cases

In recent years, the author of this essay has applied electro-acupuncture combined with the trigger point needle-embedding for treatment of primary trigeminal neuralgia in 31 cases, yielding satis- factory results as reported in the following.     

Investigation of Matrix Metalloproteinase -1, 2 and tissue inhibitor of matrix metalloproteinases-1 in Endometriosis

Objective： To explore the role of matrix metalloproteinase-1,2 （MMP-1, MMP-2） and tissue inhibitor of matrix metalloproteinases-1 （TIMP-1） in endometriosis. Methods： The eutopic and ectopic endometria from 40 subjects suffering from endometriosis and regular.endometria from 40 subjects （excluding endometriosis） were collected and examined by in situ hybridization technology and western blot assay. Results： Both expressions of MMP-1 and -2 were stronger in ectopic endometrium and eutopic endometrium than in normal endometrium. On the contrary, the expression of TIMP-1 in ectopic endometrium and eutopic endometrium was lower. The differences were significant （P 〈 0.01 ）. Moreover, there was no relationship among the expressions of MMP-1, 2 and TIMP-1 in ectopic endometrium. Conclusion： The expressions of MMP-1, 2 and TIMP-1 lose balance and lack of periodic changes in ectopic endometrium , which explains the biological invasive behavior of endometriosis. It was suggested-that regulating the balance between the MMPs and TIMP-1 should be an ideal therapeutic target to endometriosis.     

Shi Da-zhuo (史大卓) —An outstanding cardiologist of integrative medicine

Prof. SHI Da-zhuo, Ph.D., male, was born on March 20, 1960. Prof. SHI entered the Ph.D. program in 1990 at the China Academy of Chinese Medical Sciences under the supervision of Prof. CHEN Ke-ji, majoring in the treatment of cardiovascular diseases. After receiving his Ph.D. degree in 1993, Prof. SHI started working at the Cardiovascular Center in Xiyuan Hospital affiliated to China Academy of Chinese Medical sciences.     

Persist in and Carry Forward the Integrative Medical Research——Speech at the 6th National General Congress of Chinese Association of Integrative Medicine by Academician CHEN Zhu,Minister of Ministry of Health

The 6th National General Congress of Chinese Association of Integrative Medicine （CALM） was convened at 19-20, April 2008 in Beijing. Academician CHEN Zhu, the minister of Ministry of Health indicated at the congress that the integration of Chinese and Western medicine is very well in keeping with the situation of our country and the general rule of development in medical science; and as a good integration of Chinese medicine and Western medicine, it is mutually beneficial and advantageous to both of them. Seeing the creativity shown in integrative medical investigation in theoretic and methodological sides, we should and must persist in and develop it.